Short-Term Therapy with Rosiglitazone, a PPAR-γ Agonist, Improves Metabolic Profile and Vascular Function in Nonobese Lean Wistar Rats

A number of preclinical and clinical studies have reported blood-pressure-lowering benefits of thiazolidinediones in diabetic subjects and animal models of diabetes. This study was designed to further elucidate vascular effects of rosiglitazone, on healthy nonobese, lean animals. Adult male Wistar r...

Descripción completa

Detalles Bibliográficos
Autores principales: Naderali, Mohammad M., Itua, Imose, Abubakari, Abdul-Razak, Naderali, Ebrahim K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scholarly Research Network 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432376/
https://www.ncbi.nlm.nih.gov/pubmed/22957269
http://dx.doi.org/10.5402/2012/130347

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3432376/
https://www.ncbi.nlm.nih.gov/pubmed/22957269
http://dx.doi.org/10.5402/2012/130347

Ejemplares similares